Need professional-grade analysis? Visit stockanalysis.com
$761.61M
95.23
N/A
N/A
ARS Pharmaceuticals, Inc (SPRY) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $8.18.
Over the past year, SPRY has traded between a low of $6.73 and a high of $18.35. The stock has lost 45.5% over this period. It is currently 55.4% below its 52-week high.
ARS Pharmaceuticals, Inc has a market capitalization of $761.61M, with a price-to-earnings ratio of 95.23.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Side-by-side comparison against top Healthcare peers.